Found 5 hits for monomerid = 50544720 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Apelin receptor
(Homo sapiens (Human)) | BDBM50544720
(CHEMBL4632564)Show SMILES COc1cccc(OC)c1-c1cc(nn1CC(C)C)C(=O)N[C@@H](CCC1CCCCC1)CC(=O)NC1CCC1 |r,wU:22.24,(36.18,-25.4,;36.81,-26.8,;35.91,-28.05,;34.38,-27.89,;33.47,-29.13,;34.09,-30.54,;35.63,-30.71,;36.25,-32.12,;35.35,-33.36,;36.54,-29.45,;38.07,-29.61,;39.1,-28.46,;40.51,-29.09,;40.35,-30.62,;38.84,-30.94,;38.22,-32.35,;39.14,-33.59,;38.52,-35,;40.67,-33.42,;41.84,-28.31,;41.84,-26.77,;43.17,-29.08,;44.51,-28.31,;44.5,-26.77,;45.84,-26,;45.83,-24.46,;47.17,-23.69,;47.17,-22.16,;45.84,-21.38,;44.5,-22.15,;44.5,-23.7,;45.84,-29.08,;47.17,-28.3,;47.17,-26.76,;48.51,-29.07,;49.84,-28.3,;51.33,-28.7,;51.73,-27.21,;50.24,-26.81,)| Show InChI InChI=1S/C31H46N4O4/c1-21(2)20-35-26(30-27(38-3)14-9-15-28(30)39-4)19-25(34-35)31(37)33-24(17-16-22-10-6-5-7-11-22)18-29(36)32-23-12-8-13-23/h9,14-15,19,21-24H,5-8,10-13,16-18,20H2,1-4H3,(H,32,36)(H,33,37)/t24-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| PubMed
| 54 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
RTI International
Curated by ChEMBL
| Assay Description Displacement of [125I]-apelin-13 from human APJ receptor stably expressed in CHOK1 cell membrane measured after 2 hrs by topcount scintillation count... |
Bioorg Med Chem 28: (2020)
|
More data for this Ligand-Target Pair | |
Apelin receptor
(Homo sapiens (Human)) | BDBM50544720
(CHEMBL4632564)Show SMILES COc1cccc(OC)c1-c1cc(nn1CC(C)C)C(=O)N[C@@H](CCC1CCCCC1)CC(=O)NC1CCC1 |r,wU:22.24,(36.18,-25.4,;36.81,-26.8,;35.91,-28.05,;34.38,-27.89,;33.47,-29.13,;34.09,-30.54,;35.63,-30.71,;36.25,-32.12,;35.35,-33.36,;36.54,-29.45,;38.07,-29.61,;39.1,-28.46,;40.51,-29.09,;40.35,-30.62,;38.84,-30.94,;38.22,-32.35,;39.14,-33.59,;38.52,-35,;40.67,-33.42,;41.84,-28.31,;41.84,-26.77,;43.17,-29.08,;44.51,-28.31,;44.5,-26.77,;45.84,-26,;45.83,-24.46,;47.17,-23.69,;47.17,-22.16,;45.84,-21.38,;44.5,-22.15,;44.5,-23.7,;45.84,-29.08,;47.17,-28.3,;47.17,-26.76,;48.51,-29.07,;49.84,-28.3,;51.33,-28.7,;51.73,-27.21,;50.24,-26.81,)| Show InChI InChI=1S/C31H46N4O4/c1-21(2)20-35-26(30-27(38-3)14-9-15-28(30)39-4)19-25(34-35)31(37)33-24(17-16-22-10-6-5-7-11-22)18-29(36)32-23-12-8-13-23/h9,14-15,19,21-24H,5-8,10-13,16-18,20H2,1-4H3,(H,32,36)(H,33,37)/t24-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 282 | n/a | n/a | n/a | n/a |
RTI International
Curated by ChEMBL
| Assay Description Agonist activity at human APJ receptor stably expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 ... |
Bioorg Med Chem 28: (2020)
|
More data for this Ligand-Target Pair | |
Apelin receptor
(Homo sapiens (Human)) | BDBM50544720
(CHEMBL4632564)Show SMILES COc1cccc(OC)c1-c1cc(nn1CC(C)C)C(=O)N[C@@H](CCC1CCCCC1)CC(=O)NC1CCC1 |r,wU:22.24,(36.18,-25.4,;36.81,-26.8,;35.91,-28.05,;34.38,-27.89,;33.47,-29.13,;34.09,-30.54,;35.63,-30.71,;36.25,-32.12,;35.35,-33.36,;36.54,-29.45,;38.07,-29.61,;39.1,-28.46,;40.51,-29.09,;40.35,-30.62,;38.84,-30.94,;38.22,-32.35,;39.14,-33.59,;38.52,-35,;40.67,-33.42,;41.84,-28.31,;41.84,-26.77,;43.17,-29.08,;44.51,-28.31,;44.5,-26.77,;45.84,-26,;45.83,-24.46,;47.17,-23.69,;47.17,-22.16,;45.84,-21.38,;44.5,-22.15,;44.5,-23.7,;45.84,-29.08,;47.17,-28.3,;47.17,-26.76,;48.51,-29.07,;49.84,-28.3,;51.33,-28.7,;51.73,-27.21,;50.24,-26.81,)| Show InChI InChI=1S/C31H46N4O4/c1-21(2)20-35-26(30-27(38-3)14-9-15-28(30)39-4)19-25(34-35)31(37)33-24(17-16-22-10-6-5-7-11-22)18-29(36)32-23-12-8-13-23/h9,14-15,19,21-24H,5-8,10-13,16-18,20H2,1-4H3,(H,32,36)(H,33,37)/t24-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 81 | n/a | n/a | n/a | n/a |
RTI International
Curated by ChEMBL
| Assay Description Agonist activity at human APJ receptor stably expressed in CHO cells co-expressing Galphaq16 assessed as increase in intracellular calcium mobilizati... |
Bioorg Med Chem 28: (2020)
|
More data for this Ligand-Target Pair | |
Apelin receptor
(Homo sapiens (Human)) | BDBM50544720
(CHEMBL4632564)Show SMILES COc1cccc(OC)c1-c1cc(nn1CC(C)C)C(=O)N[C@@H](CCC1CCCCC1)CC(=O)NC1CCC1 |r,wU:22.24,(36.18,-25.4,;36.81,-26.8,;35.91,-28.05,;34.38,-27.89,;33.47,-29.13,;34.09,-30.54,;35.63,-30.71,;36.25,-32.12,;35.35,-33.36,;36.54,-29.45,;38.07,-29.61,;39.1,-28.46,;40.51,-29.09,;40.35,-30.62,;38.84,-30.94,;38.22,-32.35,;39.14,-33.59,;38.52,-35,;40.67,-33.42,;41.84,-28.31,;41.84,-26.77,;43.17,-29.08,;44.51,-28.31,;44.5,-26.77,;45.84,-26,;45.83,-24.46,;47.17,-23.69,;47.17,-22.16,;45.84,-21.38,;44.5,-22.15,;44.5,-23.7,;45.84,-29.08,;47.17,-28.3,;47.17,-26.76,;48.51,-29.07,;49.84,-28.3,;51.33,-28.7,;51.73,-27.21,;50.24,-26.81,)| Show InChI InChI=1S/C31H46N4O4/c1-21(2)20-35-26(30-27(38-3)14-9-15-28(30)39-4)19-25(34-35)31(37)33-24(17-16-22-10-6-5-7-11-22)18-29(36)32-23-12-8-13-23/h9,14-15,19,21-24H,5-8,10-13,16-18,20H2,1-4H3,(H,32,36)(H,33,37)/t24-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 144 | n/a | n/a | n/a | n/a |
RTI International
Curated by ChEMBL
| Assay Description Agonist activity at human APJ receptor stably expressed in CHOK1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by ... |
Bioorg Med Chem 28: (2020)
|
More data for this Ligand-Target Pair | |
Angiotensin II receptor
(Homo sapiens (Human)) | BDBM50544720
(CHEMBL4632564)Show SMILES COc1cccc(OC)c1-c1cc(nn1CC(C)C)C(=O)N[C@@H](CCC1CCCCC1)CC(=O)NC1CCC1 |r,wU:22.24,(36.18,-25.4,;36.81,-26.8,;35.91,-28.05,;34.38,-27.89,;33.47,-29.13,;34.09,-30.54,;35.63,-30.71,;36.25,-32.12,;35.35,-33.36,;36.54,-29.45,;38.07,-29.61,;39.1,-28.46,;40.51,-29.09,;40.35,-30.62,;38.84,-30.94,;38.22,-32.35,;39.14,-33.59,;38.52,-35,;40.67,-33.42,;41.84,-28.31,;41.84,-26.77,;43.17,-29.08,;44.51,-28.31,;44.5,-26.77,;45.84,-26,;45.83,-24.46,;47.17,-23.69,;47.17,-22.16,;45.84,-21.38,;44.5,-22.15,;44.5,-23.7,;45.84,-29.08,;47.17,-28.3,;47.17,-26.76,;48.51,-29.07,;49.84,-28.3,;51.33,-28.7,;51.73,-27.21,;50.24,-26.81,)| Show InChI InChI=1S/C31H46N4O4/c1-21(2)20-35-26(30-27(38-3)14-9-15-28(30)39-4)19-25(34-35)31(37)33-24(17-16-22-10-6-5-7-11-22)18-29(36)32-23-12-8-13-23/h9,14-15,19,21-24H,5-8,10-13,16-18,20H2,1-4H3,(H,32,36)(H,33,37)/t24-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
RTI International
Curated by ChEMBL
| Assay Description Agonist activity at human AGTR1 stably expressed in CHO cells assessed as increase in intracellular calcium mobilization measured at 1 sec intervals ... |
Bioorg Med Chem 28: (2020)
|
More data for this Ligand-Target Pair | |